FDA Brief

Warning letters Food

FDA warning letter to

COFISA - Conservas de Peixe da Figueira, S.A.

High riskIssued Dec 18, 2024Posted Jan 21, 2025Human Foods Program

FDA found COFISA's canned sardine and tuna food-safety plans inadequate, with missing hazards and weak histamine (spoilage toxin) controls.

What happened

FDA inspected COFISA's seafood processing facility in Figueira da Foz, Portugal, on April 10 and 12, 2024, and issued an FDA-483 (a list of inspection observations). FDA found serious violations of the seafood HACCP rule (Hazard Analysis and Critical Control Point, a required food-safety plan for hazards and controls), including a missing Staphylococcus aureus hazard, inadequate histamine limits, and food-contact surfaces not sanitized after washing and rinsing. FDA said the canned sardine and tuna products are adulterated—meaning prepared, packed, or held under conditions where they may be injurious to health—and that COFISA's May–July 2024 responses were not adequate.

What FDA found

  1. The canned sardine hazard analysis did not list Staphylococcus aureus growth and toxin formation, though the process could introduce it at one step.

    21 CFR 123.6(a), (c)(1)
  2. The sardine plan's receiving control limit for histamine was not adequate because COFISA did not get harvest-vessel records and did not measure fish temperatures when offloaded.

    21 CFR 123.6(c)(3)
  3. The sardine plan allowed lots with decomposition in more than 2.5% of fish (3 fish), instead of no more than two fish in a 118-fish sample.

    21 CFR 123.6(c)(3)
  4. The sardine plan listed two different cumulative time limits for unrefrigerated steps; the cumulative time for fish not previously frozen should not exceed 4 hours.

    21 CFR 123.6(c)(3)
  5. The corrective-action plans for canned sardines and tuna did not set a target histamine limit; FDA says reject a lot if any fish has histamine at or above 35 ppm (parts per million).

    21 CFR 123.7(b)
  6. FDA observed that COFISA did not sanitize food-contact surfaces after washing and rinsing equipment.

    21 CFR 123.11; 21 CFR 117 Subpart B

What FDA wants

FDA asks COFISA to respond in writing within 15 working days from receipt with specific corrections, including a revised HACCP plan and five consecutive days of completed monitoring records, or explain any delay and when remaining corrections will be made. FDA also warns it may refuse admission of the imported fish or fishery products and place them on detention without physical examination (DWPE, an import detention procedure).

Who should pay attention

  • US importers and distributors of canned sardines and tuna
  • brands that buy canned seafood from Portuguese processors
  • retailers and food-safety teams sourcing canned fish from this facility

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  2. Star Ocean Wholesale Foods, Inc.

    FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.

    High risk
  3. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  4. AF Import & Wholesale Co

    FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.

    High risk